Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma

by Niken M. Mahaweni, Margaretha E.H. Kaijen-Lambers, Jacqueline Dekkers, Joachim G.J.V. Aerts, Joost P.J.J. Hegmans
Published 2013-10-01

Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS

by Pauline L. de Goeje, Pauline L. de Goeje, Yarne Klaver, Yarne Klaver, Margaretha E. H. Kaijen-Lambers, Margaretha E. H. Kaijen-Lambers, Anton W. Langerak, Heleen Vroman, Heleen Vroman, André Kunert, André Kunert, André Kunert, Cor H. J. Lamers, Cor H. J. Lamers, Joachim G. J. V. Aerts, Joachim G. J. V. Aerts, Reno Debets, Reno Debets, Rudi W. Hendriks
Published 2018-09-01

Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response

by Floris Dammeijer, Cornedine J. De Gooijer, Mandy van Gulijk, Melanie Lukkes, Larissa Klaase, Lysanne A. Lievense, Cynthia Waasdorp, Merel Jebbink, Gerben P. Bootsma, Jos A. Stigt, Bonne Biesma, Margaretha E.H. Kaijen-Lambers, Joanne Mankor, Heleen Vroman, Robin Cornelissen, Paul Baas, Vincent Van der Noort, Jacobus A. Burgers, Joachim G. Aerts
Published 2021-02-01